- Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook
- Healthcare Update Week Of Nov 25: Piper Resumes On Several Biotechs
- TherapeuticsMD Applauds Congressional Leadership On Passage Of Drug Quality And Security Act
- TherapeuticsMD: Legislation To Provide Near-Term Catalyst For Investors; Maintaining Positive Outlook
- Supernus Pharma: Solid Results Demonstrate Solid Execution; Maintaining Positive Outlook
This user currently has no profile.
The Cockrell Group, Inc. is a strategic capital markets development firm focused on small-to-midcap companies. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in various areas, including private and pre-IPO activity, mergers and acquisitions, bankruptcy, executive transitions, activist shareholders, hostile takeovers, and downsizing, as well as manages events.
- Description: Investment Banker/Analyst.
- Interests: Stocks - long
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Bacterin $BONE CEO on "After the Bell" with Liz Claman at 4:20PM ET Nov 11, 2014
Latest Comments more »
- Nice write up on Why I'm Long Supernus, A Small Specialty Pharma...
- Rick,I appreciate you bring... on Supernus Pharma: Solid Results Demonstrate Soli...
- Thanks for the comment. We ... on Supernus Pharma: Solid Results Demonstrate Soli...
- Appreciate your comment. SU... on Supernus Pharma: Solid Results Demonstrate Soli...
- CEO Dan Goldberger to appea... on Bacterin International: Removal Of Overhangs Su...
Latest comments on Cockrell Group's Articles
- Chris DeMuth Jr. on TherapeuticsMD: Advancing Women's Health
- clahiji on Supernus Pharmaceuticals: 2013 Revenues Exceed ...
- marxlago on Bacterin: New CEO Positions Company For Growth
- sbrncra on Supernus Pharmaceuticals: 2013 Revenues Exceed ...
- DoctoRx on Supernus Pharmaceuticals: 2013 Revenues Exceed ...
LATEST ARTICLES & INSTAPOSTS more »